Spermosens AB (SPERM.ST)
SEK 0.01
(-3.23%)
SEK 0.01
(-3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Operating Cash Flow | -10.93 Million | -11.72 Million | -5.57 Million | -2.4 Million |
| Net Income | -12.2 Million | -12.51 Million | -6.15 Million | -2.04 Million |
| Depreciation & Amortization | 170 Thousand | 63 Thousand | - | - |
| Deferred income taxes | - | - | - | - |
| Stock-based compensation | - | - | - | - |
| Change in working capital | 1.01 Million | 811 Thousand | 851 Thousand | -362 Thousand |
| Other non-cash items | 79 Thousand | -77 Thousand | -272 Thousand | -3000.00 |
| Investing Cash Flow | -12.26 Million | -13.8 Million | -13.07 Million | -2.72 Million |
| Investments in PPE | -12.26 Million | -13.8 Million | -13.07 Million | -2.72 Million |
| Acquisitions | - | - | - | - |
| Investment purchases | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - |
| Other Investing Activities | -12.15 Million | - | - | - |
| Financing Cash Flow | 27.14 Million | 19.39 Million | 21.63 Million | 8.33 Million |
| Debt repayment | -543 Thousand | -870 Thousand | -5.01 Million | -5.5 Million |
| Dividends payments | - | - | - | - |
| Common Stock Repurchased | - | - | - | - |
| Common Stock Issuance | 18.98 Million | 18.52 Million | 26.64 Million | 2.83 Million |
| Other Financing Activities | - | 1.74 Million | - | 11 Million |
| Accounts receivables | -418 Thousand | -100 Thousand | 317 Thousand | -946.17 Thousand |
| Accounts payables | 1.43 Million | 911 Thousand | 534 Thousand | 584.27 Thousand |
| Inventory | - | - | - | - |
| Other working capital | 1.43 Million | - | - | -100.00 |
| Cash at beginning of period | 552 Thousand | 6.69 Million | 3.71 Million | 508 Thousand |
| Cash at end of period | 4.49 Million | 552 Thousand | 6.69 Million | 3.71 Million |
| Capital Expenditure | -12.26 Million | -13.8 Million | -13.07 Million | -2.72 Million |
| Effect of forex changes on cash | - | - | - | - |
| Net cash flow / Change in cash | 3.94 Million | -6.13 Million | 2.98 Million | 3.2 Million |
| Free Cash Flow | -23.2 Million | -25.52 Million | -18.65 Million | -5.13 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.36 Million | -3.21 Million | -12.2 Million | -1.99 Million | -2.8 Million | -3.4 Million |
| Depreciation & Amortization | 45 Thousand | 45 Thousand | 170 Thousand | 45 Thousand | 43 Thousand | 42 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -3.05 Million | 1.83 Million | 1.01 Million | 603 Thousand | 329 Thousand | 740 Thousand |
| Other non-cash items | -184 Thousand | 130 Thousand | 79 Thousand | -46 Thousand | -653 Thousand | 15 Thousand |
| Investing Cash Flow | -1.36 Million | -1.73 Million | -12.26 Million | -2.6 Million | -3.58 Million | -3.63 Million |
| Investments in PPE | -1.36 Million | - | -12.26 Million | - | - | -3.63 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 9.35 Million | -843 Thousand | 27.14 Million | -147 Thousand | 8.55 Million | -147 Thousand |
| Debt repayment | - | - | -543 Thousand | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 18.98 Million | - | - | - |
| Other Financing Activities | 9.35 Million | - | - | - | - | - |
| Accounts receivables | - | - | -418 Thousand | - | - | - |
| Accounts payables | - | - | 1.43 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -3.05 Million | - | - | - | - | - |
| Cash at beginning of period | 617 Thousand | 4.49 Million | 552 Thousand | 8.63 Million | 6.75 Million | 13.14 Million |
| Cash at end of period | 2.95 Million | 617 Thousand | 4.49 Million | 4.49 Million | 8.63 Million | 6.75 Million |
| Capital Expenditure | -1.36 Million | - | -12.26 Million | - | - | -3.63 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 2.34 Million | -3.87 Million | 3.94 Million | -4.14 Million | 1.88 Million | -6.38 Million |
| Free Cash Flow | -7.01 Million | -1.3 Million | -23.2 Million | -1.39 Million | -3.09 Million | -6.24 Million |
READ
600346
JACKSON
MMI
SLDX
002488